9270-25-R-RFIN-00015

The University of Mississippi's Department of Pharmaceutics and Drug Delivery is pursuing a sole source procurement for a Styl' One Nano Compaction Simulator from KORSCH America, Inc., located in Lamar County, Mississippi. The procurement is specifically for advanced pharmaceutical research equipment designed to simulate full-scale tablet manufacturing in a laboratory setting. The equipment will enable the department to enhance its research capabilities, potentially improving opportunities for government and industry grants while providing hands-on training for students in pharmaceutical product development. The solicitation, identified as procurement number 9270-25-R-RFIN-00015, was posted on January 27, 2025, with responses due by February 11, 2025, at 10:00 am Central Time. Interested parties who object to the sole source certification must submit their responses to the UM Procurement Services Department through hand delivery, mail, overnight delivery, or email. The proposed equipment is compatible with existing departmental resources, including powder blending, granulation, tablet press, and coating equipment. KORSCH America will provide training as part of the corporate partnership for the Hands-on Course in Tablet Technology.

The procurement appears to be unrestricted, with no specific set-aside designations for disadvantaged enterprises mentioned in the documentation. KORSCH America, Inc. is the sole vendor under consideration, having negotiated a 23% discount that renders the purchase price competitive compared to similar pilot-scale equipment. The total project cost is not explicitly stated, but the vendor has positioned the equipment as a cost-effective solution compared to comparable technologies that can cost two to three times more. The equipment will integrate with the department's existing pharmaceutical research infrastructure, including powder processing and tablet manufacturing equipment. The procurement seems focused on enhancing research capabilities and educational training rather than a traditional commercial procurement. No specific budget range or award value was disclosed in the available documentation. The procurement appears tailored specifically to the University of Mississippi's pharmaceutical research and educational objectives, with potential long-term benefits for student training and research grant acquisition.